Ten things you should know about transposable elements

G Bourque, KH Burns, M Gehring, V Gorbunova… - Genome biology, 2018 - Springer
Transposable elements (TEs) are major components of eukaryotic genomes. However, the
extent of their impact on genome evolution, function, and disease remain a matter of intense …

Engineering and design of chimeric antigen receptors

S Guedan, H Calderon, AD Posey, MV Maus - Molecular Therapy-Methods …, 2019 - cell.com
T cells engineered with chimeric antigen receptors (CARs) have emerged as a potent new
class of therapeutics for cancer, based on their remarkable potency in blood cancers. Since …

An electrogenetic interface to program mammalian gene expression by direct current

J Huang, S Xue, P Buchmann, AP Teixeira… - Nature …, 2023 - nature.com
Wearable electronic devices are playing a rapidly expanding role in the acquisition of
individuals' health data for personalized medical interventions; however, wearables cannot …

[HTML][HTML] Chemical-induced chromatin remodeling reprograms mouse ESCs to totipotent-like stem cells

M Yang, H Yu, X Yu, S Liang, Y Hu, Y Luo, Z Izsvák… - Cell Stem Cell, 2022 - cell.com
Totipotent cells have more robust developmental potency than any other cell types, giving
rise to both embryonic and extraembryonic tissues. Stable totipotent cell cultures and …

Genetically engineered cerebral organoids model brain tumor formation

S Bian, M Repic, Z Guo, A Kavirayani, T Burkard… - Nature …, 2018 - nature.com
Brain tumors are among the most lethal and devastating cancers. Their study is limited by
genetic heterogeneity and the incompleteness of available laboratory models. Three …

Cerebral organoids at the air–liquid interface generate diverse nerve tracts with functional output

SL Giandomenico, SB Mierau, GM Gibbons… - Nature …, 2019 - nature.com
Neural organoids have the potential to improve our understanding of human brain
development and neurological disorders. However, it remains to be seen whether these …

The past, present, and future of non-viral CAR T cells

A Moretti, M Ponzo, CA Nicolette… - Frontiers in …, 2022 - frontiersin.org
Adoptive transfer of chimeric antigen receptor (CAR) T lymphocytes is a powerful technology
that has revolutionized the way we conceive immunotherapy. The impressive clinical results …

CARAMBA: a first-in-human clinical trial with SLAMF7 CAR-T cells prepared by virus-free Sleeping Beauty gene transfer to treat multiple myeloma

S Prommersberger, M Reiser, J Beckmann, S Danhof… - Gene therapy, 2021 - nature.com
Clinical development of chimeric antigen receptor (CAR)-T-cell therapy has been enabled
by advances in synthetic biology, genetic engineering, clinical-grade manufacturing, and …

Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells

P Kebriaei, H Singh, MH Huls… - The Journal of …, 2016 - Am Soc Clin Investig
BACKGROUND. T cells expressing antigen-specific chimeric antigen receptors (CARs)
improve outcomes for CD19-expressing B cell malignancies. We evaluated a human …

Guided self-organization and cortical plate formation in human brain organoids

MA Lancaster, NS Corsini, S Wolfinger… - Nature …, 2017 - nature.com
Three-dimensional cell culture models have either relied on the self-organizing properties of
mammalian cells 1, 2, 3, 4, 5, 6 or used bioengineered constructs to arrange cells in an …